ArticleMicrobiology spectrum2026
Prebiotics as adjunctive treatment ameliorates DSS-induced colitis and gut microbiota.
Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Psychological stress and gut microbiota regulation of osteoarthritis progression: mechanisms and therapeutic strategies.Frontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The disturbance of gut microbiota is closely related to the occurrence and development of inflammatory bowel disease (IBD), which can be improved by the supplementation of prebiotics. The therapeutic benefits of exclusive enteral nutrition (EEN) on patients with IBD are variable, and it has adverse effects on gut microbiota. Therefore, it is necessary to explore the efficacy of EEN combined with prebiotics on colitis and gut microbiota. In our study, mice were administered distilled water containing 4% dextran sodium sulfate (DSS) to induce colitis, then fed with normal water, EEN, EEN combined with isomaltooligosaccharide (IMO), EEN combined with fructo-oligosaccharide (FOS), and EEN combined with polydextrose (POL) for 1 week, respectively. The results revealed that EEN combined with prebiotic treatments showed more benefits in alleviating DSS-induced colitis than EEN treatment, among which FOS exhibited superior efficacy, including reducing disease activity index (DAI) (8.67 ± 0.52 vs 9.67 ± 0.82) and preventing colon shortening (7.23 ± 0.33 vs 6.43 ± 0.28 cm). Compared with the DSS group (7.00 [interquartile range, IQR: 5.75-8.25]), the histological score of IMO (2.50 [IQR: 2.00-4.00]), FOS (2.50 [IQR: 0.00-3.00]), and POL (2.00 [IQR: 1.50-7.25]) groups was obviously lower. In addition, prebiotics as adjunctive treatment increased more beneficial species than EEN treatment. Compared with the DSS group, POL adjuvant treatment enhanced the Simpson index, altered the overall structure of the gut microbiota, and IMO adjuvant treatment improved the F/B ratio (0.28 [IQR: 0.12-0.64] vs 1.06 [IQR: 0.87-2.82]). This study proved that prebiotics as adjuvant therapy improved colitis by regulating gut microbiota, providing a foundation for clinical application. IMPORTANCE: We demonstrated the superior efficacy of prebiotics as adjuvant therapy in improving clinical outcomes (body weight, colonic length, disease activity index, and histological score) and modulating the structure and composition of gut microbiota in dextran sodium sulfate-induced colitis in mice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.